Results 111 to 120 of about 1,395,710 (388)

Spontaneous regression of mantle cell lymphoma: a report of four cases

Cancer Communications, 2018
Background Spontaneous regression has been reported in some indolent forms of lymphoma. Mantle cell lymphoma (MCL) is an aggressive lymphoid neoplasm and has a poor prognosis.
Haige Ye, Aakash Desai, Tiejun Gong, Dongfeng Zeng, Krystle Nomie, Wendy Chen, Wei Wang, Jorge Romaguera, Michael L. Wang   +8 more
doaj   +1 more source

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.

Blood, 2017
Primary central nervous system (CNS) lymphoma (PCNSL) and primary testicular lymphoma (PTL) are rare extranodal large B-cell lymphomas with similar genetic signatures.
L. Nayak, F. Iwamoto, A. LaCasce, S. Mukundan, M. Roemer, B. Chapuy, P. Armand, S. Rodig, M. Shipp   +8 more
semanticscholar   +1 more source

Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation

Molecular Oncology, EarlyView.
Cyclin D1 overexpression altered the cell adhesion pathway, while cyclin D2 upregulation had less impact on pathway enrichment analysis. Multiple myeloma (MM) patients with cyclin D1 overexpression showed reduced CD56 expression and increased circulating tumor cells (CTC) levels, suggesting that cyclin D1 may contribute to MM cell dissemination ...
Ignacio J. Cardona‐Benavides, Sara Cristobal‐Vargas, Cristina De Ramón, Elizabeta A. Rojas, Irena Misiewicz‐Krzeminska, Isabel Isidro, José Juan Pérez, Bruno Paiva, Noemi Puig, Miguel Alcoceba, María‐Victoria Mateos, Luis A. Corchete, Myriam Cuadrado, Norma C. Gutiérrez   +13 more
wiley   +1 more source

PB2101: TREATMENT OF AGGRESSIVE B-CELL LYMPHOMA WITH DA-EPOCH-R, A SINGLE CENTRE EXPERIENCE

HemaSphere, 2022
E.-K. Dimitraki, C. Giatra, M. Delatola, A. Roumelioti, L. Ligdi, P. Kosmas, V. Drakopoulou, E. Souravla, I. Darmani, G. Kanelis, L. Marinos, K. Sakellariou, D. Karakasis, M. Bakiri, M. Bouzani   +14 more
doaj   +1 more source

Costs associated with febrile neutropenia in solid tumor and lymphoma patients - an observational study in Singapore. [PDF]

, 2014
BackgroundThe primary objective was to describe the total direct inpatient costs among solid tumor and lymphoma patients with chemotherapy-induced febrile neutropenia (FN) and the factors that were associated with higher direct cost.
A Bosly, A Chan, A Ihbe-Heffinger, AG Freifeld, Alexandre Chan, B Dulisse, C O’Brien, CL Bennett, GH Lyman, GH Lyman, GH Lyman, H Khalili, J Klastersky, JI Mayordomo, Li Yang Hsu, LM Poon, M Wong, Mabel Wong, MB Schilling, NM Kuderer, SL Michels, SY Liou, V Caggiano, Xiao Jun Wang, YP Zhou   +24 more
core   +2 more sources

Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.

New England Journal of Medicine, 2015
BACKGROUND It is unclear whether patients with early-stage Hodgkin's lymphoma and negative findings on positron-emission tomography (PET) after three cycles of chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) require ...
J. Radford, T. Illidge, N. Counsell, B. Hancock, R. Pettengell, P. Johnson, J. Wimperis, D. Culligan, B. Popova, Paul Smith, A. McMillan, A. Brownell, A. Kruger, A. Lister, P. Hoskin, M. O'Doherty, S. Barrington   +16 more
semanticscholar   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Haematologica, 2022
Andrew P. Jallouk, Sushanth Gouni, Jason Westin, Lei Feng, Haleigh Mistry, Raphael E. Steiner, Jinsu James, Mansoor Noorani, Sandra Horowitz, Nahum Puebla-Osorio, Luis E. Fayad, Swaminathan P. Iyer, Misha Hawkins, Christopher R. Flowers, Sairah Ahmed, Loretta J. Nastoupil, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Yago Nieto, Paolo Strati   +20 more
doaj   +1 more source

Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW. [PDF]

, 2017
Purpose: B-cell lymphomas must acquire resistance to apoptosis during their development. We recently discovered BCLW, an antiapoptotic BCL2 family member thought only to contribute to spermatogenesis, was overexpressed in diffuse large B-cell lymphoma ...
Adams, Clare M., Eischen, Christine M., Gong, MD, Jerald Z., Mitra, Ramkrishna   +3 more
core   +1 more source

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Blood, 2006
Because the causes of most lymphoid neoplasms remain unknown, comparison of incidence patterns by disease subtype may provide critical clues for future etiologic investigations.
L. Morton, Sophia S. Wang, S. Devesa, P. Hartge, D. Weisenburger, M. Linet   +5 more
semanticscholar   +1 more source